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Summary
The response of thymocytes to pre-T cell receptor
(pre-TCR) signaling includes proliferation and gene re-
arrangement, two cellular processes that are incom-
patible. The control of proliferation by pre-TCR signals
depends on the activities of the transcription factors
RORgt, Egr3, E12, and E47. Here, we describe a regula-
tory network in which interplay between these factors
ensures transient proliferation that is temporally dis-
tinct from gene rearrangement. RORgt expression
was elevated after pre-TCR signaling, and RORgt pro-
moted gene rearrangement in CD4+, CD8+ cells by in-
hibiting cell division, promoting survival via Bcl-XL,
and inducing Rag2. Egr3 was transiently induced by
pre-TCR signals and promoted a distinct proliferative
phase by reducing E protein-dependent RORgt ex-
pression and interacting with RORgt to prevent induc-
tion of target genes. After Egr3 subsided, the expres-
sion and function of RORgt increased. Thus,
transient induction of Egr3 delays the effects of RORgt
and enables pre-TCR signaling to induce both prolifer-
ation and gene rearrangement.
Introduction
Expression of the pre-T cell receptor (pre-TCR) in imma-
ture thymocytes results in intracellular signaling that has
numerous consequences for thymocyte development.
Signals downstream of the pre-TCR decrease expres-
sion of pre-T a (pTa) and CD25 increase expression of
the CD4 and CD8 coreceptors and induce a period of
rapid proliferation (Godfrey and Zlotnik, 1993). This pro-
liferation is important for the expansion of clones that
have a functional TCR b chain, ensuring a large pool of
candidates that can be auditioned for inclusion in the T
cell repertoire based on the ability to form a TCR ab het-
erodimer that interacts appropriately with self peptide
presented by MHC molecules. The induction of CD4
and CD8 expression and rapid expansion of pre-TCR+
cells results in the majority of thymocytes bearing
a CD4, CD8 double positive (DP) phenotype.
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cisco, California 94080.An essential property of the resulting DP cells is that
they enter a nonproliferative phase. Soon after thymo-
cytes become DP cells, they begin the process of gene
rearrangement at the TCR a locus. This process involves
the creation of double-strand breaks in DNA and is
therefore incompatible with DNA replication. The pre-
TCR therefore initiates a period of rapid proliferation
that must be kept temporally distinct from the gene rear-
rangement that follows. The mechanism by which pre-
TCR signals can induce distinct phases of proliferation
and rearrangement has not been described.
A key player in the establishment of the DP thymocyte
phenotype is the orphan nuclear hormone receptor
RORgt (He, 2002; Jetten et al., 2001; Jetten and Ueda,
2002). RORgt is an isoform of RORg that is expressed
only in DP thymocytes and lymphoid tissue inducer cells
(Eberl et al., 2004; He et al., 1998, 2000). RORgt-deficient
mice lack lymph nodes and also have DP thymocytes
that show signs of increased cell-cycle activity (Sun
et al., 2000). DP thymocytes in RORgt-deficient mice
also have poor survival, resulting in an abnormally small
thymus, despite the enhanced proliferation (Kurebaya-
shi et al., 2000; Sun et al., 2000). These results suggest
that RORgt promotes survival and inhibits proliferation
of DP thymocytes. Although expression of RORgt would
be expected to be antagonistic to the proliferative phase
that follows pre-TCR signaling, we have found that pre-
TCR signals induce a delayed elevation in RORgt ex-
pression (Xi and Kersh, 2004b). We have proposed
a model where the delayed induction of RORgt allows
for a period of proliferation to occur after pre-TCR
signaling.
Early growth response gene 3 (Egr3) has also been im-
plicated in mediating the effects of pre-TCR signaling. It
has been established that pre-TCR signals induce ex-
pression of the Egr family members 1, 2, and 3 (Carleton
et al., 2002; Shao et al., 1997; Xi and Kersh, 2004a).
These transcriptional regulators bind DNA via zinc fin-
gers and are induced in a variety of cell types (Chavrier
et al., 1988; Crosby et al., 1991; Milbrandt, 1987; Yama-
gata et al., 1994). Egr3-deficient mice have reduced pro-
liferation in response to pre-TCR signals (Xi and Kersh,
2004a), suggesting that Egr3 promotes proliferation.
Thymocytes in which Egr3 is expressed as a transgene
under the control of the CD2 promoter and enhancer
(Egr3TG mice) have a phenotype that is indistinguish-
able from the thymic phenotype of RORgt-deficient
mice (Guo et al., 2002; Kurebayashi et al., 2000; Sun
et al., 2000; Xi and Kersh, 2004b), and indeed Egr3TG
mice have low expression of RORgt (Xi and Kersh,
2004b). Because Egr3 is induced immediately after
pre-TCR signals and subsides by the time RORgt ex-
pression is increased (Xi and Kersh, 2004b), it is possible
that Egr3 promotes proliferation in response to pre-TCR
signals by delaying the induction of RORgt.
The E proteins are basic helix-loop-helix (bHLH) con-
taining transcriptional regulators that include E12, E47
(both encoded by the E2A gene), and HEB. E2A-defi-
cient mice have multiple defects in thymocyte develop-
ment including the occurrence of T lymphomas at a high
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814frequency (Bain et al., 1997). These lymphomas have an
immature thymocyte phenotype and appear to arise
from deregulated proliferation at the DN to DP transition.
It has been proposed that one of the functions of E pro-
teins is to enforce a proliferation checkpoint (Engel and
Murre, 2004). Pre-TCR signaling results in a decrease in
E protein activity (Bain et al., 1999), and this allows pro-
Figure 1. RORgt Regulates the Resting DP Thymocyte Phenotype
(A) RORgt induces Bcl-XL expression in DP cells. D9 cells were
transduced with the retrovirus expressing EGFP only (mock) or
myc-tagged RORgt plus EGFP. Transduction efficiency was at least
80% as assessed by measuring EGFP expression. RNA and whole-
cell lysates were isolated 2 days after transduction. Bcl2l1 mRNA
(coding for Bcl-XL) was measured by QR-PCR and normalized to
b-actin RNA (left). The data show the relative change of Bcl2l1
RNA (mean6 SD, 4 independent experiments) in RORgt-transduced
cells compared to mock transduced cells. Bcl-XL protein expression
was measured by immunoblotting (right). Two representative trans-
duction experiments are shown.
(B) RORgt induces Rag2 expression in DP cells. D9 cells were trans-
duced as in (A). Rag1 and Rag2 RNA was measured by QR-PCR and
normalized to b-actin RNA. The data show the relative change (mean
6 SD, 3 experiments) of Rag1 and Rag2 RNA in RORgt-transduced
cells or thymocytes compared to mock transduced cells.
(C) RORgt negatively regulates DP cell proliferation. D9 cells were
transduced as in (A). Cell-cycle analysis was performed by 7-AAD
staining of transduced D9 cells 36 to 48 hr after transduction. Num-
bers show the percentage of cells in G0 and G1 or in S, G2, and M
phases of the cell cycle. Data represent at least three independent
experiments.
(D) Time course analysis of EGFP expression in transduced D9 cells.
EGFP expression was analyzed at day 0 (36 to 48 hr posttransduc-
tion) and monitored daily for the next 8 days. The percentage of re-
maining EGFP+ cells was determined by dividing the percentage of
EGFP+ cells at each time point by the percentage of EGFP+ cells at
day 0. The data represent means 6 SD of three experiments.liferation to proceed until E protein activity is elevated
again.
Here, we show that RORgt, Egr3, and E proteins are
involved in a complex regulatory network that ensures
a period of rapid proliferation that is distinct from the fol-
lowing resting phase wherein TCR a gene rearrange-
ment occurs. RORgt established the resting DP thymo-
cyte phenotype by increasing expression of Bcl-XL and
Rag2 and direct induction of murine cytoplasmic polya-
denylation element binding protein four (mCPEB4), an
RNA binding protein that we show inhibited cell division.
Because the effects of RORgt expression are incompat-
ible with pre-TCR signal-induced cell division, RORgt
function must be delayed after pre-TCR signaling so
that proliferation can occur. To understand how pre-
TCR signals cause delayed induction of RORgt, we eval-
uated the RORgt promoter. We found that binding of E
proteins to the promoter enhanced RORgt expression
and that Egr3 inhibited RORgt expression by inducing
the E protein inhibitor Id3. Although the reduction of
RORgt expression by Egr3 is substantial in both cell
lines and in Egr3TG mice, it is not complete (Xi and
Kersh, 2004b). Despite this, Egr3TG mice closely resem-
ble RORgt-deficient mice (Xi and Kersh, 2004b). We
found that an additional mechanism by which Egr3
blocked RORgt function was by an interaction between
the RORgt and Egr3 proteins. Thus, Egr3 establishes
a period of proliferation in response to pre-TCR signals
by inhibition of RORgt expression and RORgt function.
The transient nature of Egr3 expression enables RORgt
function to be elevated only after several rounds of pro-
liferation, whereupon RORgt establishes a resting
phase, promotes survival, and allows for the rearrange-
ment of TCR a.
Results
Regulation of Resting DP Thymocyte Phenotype
by RORgt
RORgt-deficient thymocytes have a high percentage of
proliferating cells, poor survival at the DP stage, low ex-
pression of Bcl-XL and Rag2, and altered TCR a gene re-
arrangement (Guo et al., 2002; He, 2000; Sun et al.,
2000). These phenotypes could be a direct result of the
removal of RORgt or may be secondary to a develop-
mental block. For example, enhanced proliferation and
low Bcl-XL expression would be observed if there was
rapid death of DP cells at the end of the proliferative
burst after pre-TCR signaling. To help clarify whether
these effects were a direct result of the loss of RORgt ex-
pression, we have used a bicistronic retroviral vector to
overexpress a myc-tagged version of RORgt and en-
hanced green fluorescent protein (EGFP) in the DP thy-
mocyte cell line 16610D9 (D9). This is a cell line derived
from a p53-deficient mouse that expresses low amounts
of RORgt and Bcl-XL compared to primary thymocytes
(data not shown). We have found via quantitative real-
time RT-PCR (QR-PCR) that RORgt overexpression in-
duced a greater than 4-fold increase in Bcl-XL and
Rag2 RNA in D9 cells compared to expression of
EGFP alone (Figure 1). Increases in Bcl-XL protein
were also observed (Figure 1A). In contrast, there was
very little induction of Rag1 (Figure 1B). We also found
that retroviral transduction of RORgt into D9 cells
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(A) Two consensus RORgt binding elements (RORE) are located in the intron 3 of mCpeb4 gene. After ChIP on normal thymocytes, PCR was
performed with primers specific for mCpeb4 and hypoxanthine guanine phosphoribosyl transferase (HPRT). Purified hamster IgG served as
the control antibody.
(B) Expression of mCPEB4 isoforms in thymocytes and D9 cells. Total RNA from thymocytes and D9 cells was analyzed by RT-PCR (40 cycles)
with primers that amplify all four mCPEB4 isoforms (a–d). Positive controls were derived by PCR by means of plasmids containing cloned indi-
vidual mCPEB4 isoforms.
(C) RORgt positively regulates mCPEB4 expression. D9 cells were transduced with the retrovirus expressing EGFP only (mock) or RORgt as in
Figure 1. mCPEB4 expression was analyzed 2 days after transduction by semiquantitative RT-PCR (28 cycles) with serially diluted cDNA (1:1, 1:5,
1:10) as shown by the wedges.
(D) mCpeb4 expression was assessed by QR-PCR with RNA described in (C). The data show the relative change of mCpeb4 RNA (mean6 SD, 4
experiments) in RORgt-transduced cells compared to mock transduced cells.
(E) ReducedmCpeb4 expression in Egr3TG thymocytes.mCpeb4 expression in thymocytes of Egr3TG mice was assessed by QR-PCR. The data
show the relative change (mean 6 SD) of mCpeb4 RNA in Egr3TG mice compared to nontransgenic littermate controls (NLC) (4 Egr3TG mice
were compared to 4 littermate controls).
(F) mCPEB4 inhibits DP cell proliferation. D9 cells were transduced with the retrovirus expressing EGFP only (mock), mCPEB4-a, mCPEB4-b,
mCPEB4-d, or RORgt. Cell-cycle analysis was performed 24 to 36 hr after transduction. Expression of the transduced proteins was confirmed
by immunoblot with an HA antibody (Figure S1). The transduction efficiency was at least 80% for each experiment. Data represent at least three
independent experiments.resulted in a reduction in the percentage of cells that
were in the S, G2, and M phases of the cell cycle
(Figure 1C). This resulted in EGFP+ cells (those that ex-
pressed RORgt) being overgrown by EGFP2 cells by
6–8 days after transduction (Figure 1D). The data show
that high RORgt expression results in increases in ex-
pression of Bcl-XL and Rag2 and that RORgt inhibits
cell-cycle progression.
mCpeb4 Is an RORgt Target Gene that Inhibits
Cell Division
To understand the mechanism by which RORgt regu-
lates the DP thymocyte phenotype, we sought to identify
direct transcriptional targets of RORgt by performing
a chromatin immunoprecipitation (ChIP) cloning assay.An antibody against RORgt was used to immunoprecip-
itate crosslinked chromatin from murine thymocytes,
and the precipitated DNA fragments were cloned and
sequenced. One of the clones obtained had a sequence
that corresponded to intron 3 of the murine cytoplasmic
polyadenylation element binding protein 4 (mCpeb4)
gene. This sequence contains two consensus RORgt
binding elements (RORE) (Figure 2A). PCR amplification
of the DNA fragments obtained by ChIP from thymo-
cytes by means of the RORgt antibody confirmed that
RORgt was bound to this segment of the mCpeb4
gene in vivo (Figure 2A). Murine CPEB4 exists in four iso-
forms (a–d) (Theis et al., 2003), and RT-PCR was used to
determine which isoforms were expressed in the thy-
mus. As shown in Figure 2B, 40 cycles of amplification
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thymus and D9 cells. The b and d isoforms are the major
mCPEB4 isoforms expressed in thymocytes and D9
cells, as shown by the fact that 28 cycles of PCR de-
tected only the b and d isoforms (Figure 2C and data
not shown). Transduction of D9 cells with a retrovirus
encoding RORgt resulted in an increase in expression
of the b and d forms of mCPEB4 (Figure 2C). QR-PCR
demonstrated a 5-fold increase in totalmCpeb4 RNA af-
ter transduction of D9 cells with an RORgt-encoding vi-
rus. In addition, we found that mCpeb4 expression was
reduced by nearly 60% in Egr3TG thymocytes (Fig-
ure 2E), which have reduced RORgt expression and
function (Xi and Kersh, 2004b). Thus, RORgt is a direct
positive regulator of expression of the b and d isoforms
of mCPEB4 in thymocytes. mCPEB4 is an RNA binding
protein and a member of a protein family that controls
protein translation by regulating the length of the poly
A tail (Mendez and Richter, 2001). Because other mem-
bers of the CPEB family have been implicated in cell-
cycle control (Groisman et al., 2000, 2002; Stebbins-
Boaz et al., 1996; Tay et al., 2000), we speculated that
mCPEB4 could play a role in mediating the ability of
RORgt to take cells out of the cell cycle. When we ex-
pressed either the a, b, or d isoform of HA-tagged
mCPEB4 in D9 cells, we found that indeed, 24 to 36 hr
after transduction, the percentage of cells in S, G2,
and M phases of the cell cycle was reduced to a similar
extent as when RORgt was overexpressed (Figure 2F).
Expression of the mCPEB4 isoforms was confirmed by
immunoblot (see Figure S1 in the Supplemental Data
available with this article online). Thus, RORgt regulates
mCPEB4 expression in thymocytes, and mCPEB4 is
potentially responsible for the ability of RORgt to inhibit
cell division.
Egr3 Inhibits RORgt Promoter Activity
RORgt expression is induced by pre-TCR signals, but
expression is not appreciable until 36 hr (Xi and Kersh,
2004b). The role of RORgt in cell-cycle inhibition and
promotion of TCR a gene rearrangement suggests that
delayed induction of RORgt is critical for the proliferative
burst that follows pre-TCR signaling. Because Egr3TG
mice have a phenotype that strongly resembles
RORgt-deficient mice, we speculated that Egr3, which
is rapidly induced by pre-TCR signals, could act as a re-
pressor of RORgt promoter activity. To test this idea, we
identified the start site of RORgt transcription. The Rorc
gene encodes both RORg and RORgt. These gene prod-
ucts share exons 3–11, but RORgt does not use exons 1
and 2 of RORg, replacing them with the unique 1gt exon
(Figure 3A; He et al., 1998; Medvedev et al., 1996, 1997;
Villey et al., 1999). 50 RACE revealed that the major
RORgt transcription start site (TSS) is located just up-
stream of the 1gt exon (Figure S2). We then generated
a series of constructs containing various lengths of se-
quence upstream of the TSS cloned into the pGL3 lucif-
erase reporter vector. Transfection of these deletion
constructs into D9 cells resulted in robust luciferase ac-
tivity, with most of the activity contained within a con-
struct that included bases 2242 to +109 relative to the
TSS (Figure 3B). Transfection of other cell lines that
are negative for expression of RORgt did not produce
any luciferase activity (Figure S3). An evaluation of theDNA sequence in this region revealed several consen-
sus transcription factor binding sites that were con-
served between mouse, rat, and human sequences
(Figure S2). To determine whether Egr3 was inhibitory
for RORgt promoter activity, we cotransfected increas-
ing amounts of a plasmid encoding FLAG-tagged Egr3
along with the 2242 to +109 RORgt promoter reporter
construct. We found that Egr3 was a potent inhibitor of
the RORgt promoter in D9 cells and that the 2242 to
+109 region of the RORgt promoter contained all of the
necessary elements for Egr3 to mediate repression
(Figure 3C). In contrast, luciferase activity driven by the
SV40 promoter was not inhibited by Egr3 (Figure 3C).
Thus, Egr3 is a negative regulator of the RORgt promoter
in D9 cells.
To determine whether Egr3 represses RORgt expres-
sion in pre-TCR-stimulated thymocytes, we examined
Egr3-deficient mice. We have previously shown that
Egr3-deficient thymocytes have increased RORgt ex-
pression compared to wild-type thymocytes (Xi and
Kersh, 2004b). To look specifically at thymocytes re-
sponding to pre-TCR signals, we sorted DN3, DN4,
and DP cells from wild-type and Egr3-deficient thy-
muses and measured RORgt RNA expression by QR-
PCR. We found that in normal thymocytes, RORgt was
higher in the DN4 than the DN3 cells and reached high
amounts in the DP population (Figure 3D). The induction
of RORgt in the DN4 population was 4-fold greater in
DN4 cells derived from Egr3-deficient mice compared
to wild-type, suggesting that Egr3 represses RORgt ex-
pression in this population that has recently experi-
enced pre-TCR signaling (Figure 3D). In contrast, an-
other Egr family member, Egr1, was induced equally
in wild-type and Egr3-deficient DN4 thymocytes (Fig-
ure 3D). Importantly, we also found that Egr3 was
induced in DN4 cells compared to DN3 in wild-type
thymocytes (Figure 3D). These results suggest that
pre-TCR signals induce expression of Egr3 in vivo and
that Egr3 expression represses RORgt in cells that are
responding to pre-TCR signals.
E Proteins Positively Regulate RORgt Expression
The sequence of the 2242 to +109 region of the RORgt
promoter does not contain any consensus Egr binding
sites, but it does contain four E boxes, sites expected
to be bound by members of the E protein family. The
ability of Egr1 to inhibit E protein activity has been dem-
onstrated (Bain et al., 2001), so we investigated the im-
portance of these E boxes as a possible mechanism
by which Egr3 could influence RORgt expression. We
found that mutation of E box 1 (E1) and 2 (E2) had mini-
mal effect on promoter activity, whereas mutation of E
box 3 (E3) or 4 (E4) both substantially reduced activity
(Figure 4A). Mutation of both E3 and E4 reduced pro-
moter activity even further. To determine whether E pro-
teins could bind to these sites, an electrophoretic mobil-
ity shift assay (EMSA) was performed (Figure 4B). This
assay shows that specific protein-DNA complexes are
formed by incubation of nuclear extracts from D9 cells
with oligonucleotides containing either the E3 or E4 se-
quences. Extracts from the E2A-deficient thymoma 1.F9
failed to generate any specific E protein-DNA com-
plexes. The complexes formed by D9 extracts can be
supershifted by antibodies against E12, E47, and to
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(A) Genomic structure of the Rorc gene. RORgt uses a unique first exon (1gt) and is driven by an alternate promoter (Pgt). The putative cis reg-
ulatory elements of the RORgt promoter are shown.
(B) 2242 to +109 region of the RORgt promoter contains essential elements for RORgt expression in DP cells. Serial deletion variants of the
mouse RORgt promoter firefly luciferase construct (10 mg) were transfected into D9 cells. Luciferase activity was measured 24 hr after transfec-
tion. Relative luciferase activity was determined by normalizing firefly luciferase activity to Renilla luciferase activity driven by the thymidine ki-
nase promoter (pRL-TK). The data show the means 6 SD of a triplicate experiment and represent three similar experiments.
(C) 2242 to +109 region of the RORgt promoter mediates transcriptional repression of RORgt by Egr3. The indicated luciferase reporter con-
structs (10 mg) were cotransfected into D9 cells with increasing amount (5, 10, 20, 30 mg) of FLAG-Egr3 expression vector. Luciferase activity
was measured 48 hr posttransduction as in (B). The data show the means6 SD of a triplicate experiment and represent four similar experiments.
The expression of FLAG-Egr3 was analyzed by immunoblotting with a FLAG antibody.
(D) The expression of RORgt, Egr1, and Egr3 was analyzed by QR-PCR on DN3, DN4, and DP thymocytes isolated from the pooled thymuses of
three Egr3+/+ and Egr32/2mice. Data are normalized to b-actin expression. The expression of RORgt, Egr1, and Egr3 in the DN3 subset of Egr3+/+
mice was set to 1. The data represent the mean 6 SEM of triplicate reactions. N.D., not detected.a lesser extent HEB. To confirm that E proteins were
binding these sites in vivo, ChIP was performed with
antibodies against E12, E47, and HEB to precipitate
chromatin from thymocytes. PCR analysis of the precip-
itated DNA revealed that all three proteins were bound to
the RORgt promoter in primary thymocytes (Figure 4C).
To test the idea that the inhibition of RORgt promoter
activity by Egr3 was a result of E protein inhibition, we
cotransfected D9 cells with Egr3 and a titration of E pro-
tein expression vectors. Increasing amounts of plas-mids encoding E12 or E47 could completely eliminate
the inhibition caused by a constant dose of Egr3 (Fig-
ure 4D). Coexpression of HEB did not seem to have
any effect on Egr3-mediated inhibition (Figure 4D). The
failure of HEB to rescue RORgt promoter activity could
be because HEB homodimers are unable to activate
the promoter or because HEB may only be able to
bind one of the E boxes in vivo. To examine whether E
proteins can promote endogenous RORgt expression,
we ectopically expressed E47 in 1.F9 cells by means of
Immunity
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(A) Two proximal E boxes are essential for the RORgt promoter activity in DP cells. The putative E boxes at297,243,235, and +79 of the RORgt
promoter were mutated either separately or in combination as indicated. D9 cells were transfected with the mutant promoter luciferase con-
structs, and luciferase activity was determined as in Figure 3B. Black boxes indicate mutated E boxes, and white boxes indicate unmutated se-
quence. The data show the means 6 SD of a triplicate experiment and represent three similar experiments.
(B) E proteins bind the E boxes of the RORgt promoter in vitro. Nuclear extract from D9 cells was analyzed by EMSA with oligonucleotide probes
containing the E box at either235 (E3) or +79 (E4) of the RORgt promoter. For competition analysis, 1003molar excess of either the wild-type (wt)
or mutated (mut) E box was preincubated with the nuclear extract for 20 min. For antibody supershifting analysis, the rabbit polyclonal anti-E12,
anti-E47, anti-HEB, or negative control antibody was added to the nuclear extract. Nuclear extract from 1.F9 cells, an E2A-deficient thymoma cell
line, was used as negative control.
(C) E proteins bind the E boxes of the RORgt promoter in vivo. Chromatin of murine thymocytes was immunoprecipitated with E12, E47, HEB, or
control antibody. The precipitated and input DNA fragments were analyzed by PCR with primers encompassing E3, E4, or both. PCR of the HPRT
promoter served as negative control.
(D) Overexpression of E proteins overcomes Egr3-mediated repression of the RORgt promoter. The2242 region of the RORgt promoter (10 mg)
was cotransfected into D9 cells with Egr3 expression vector (5 mg) either alone or in the presence of increasing amount (5, 10, 20 mg) of E12, E47,
or HEB expression vector. Luciferase activity was analyzed 48 hr posttransfection as in Figure 3B. The data show the means6 SD of a triplicate
experiment and represents three similar experiments.
(E) E47 activates endogenous RORgt expression. 1.F9 cells were transduced with bicistronic retroviruses expressing E47-ER or bHLH-ER with
hCD25. The transduced cells were treated with 4-OHT dissolved in ethanol to induce dimerization. hCD25+ cells were purified and analyzed by
QR-PCR for the expression of RORgt. The amounts of RORgt transcripts were normalized to those of the ARP control transcripts. The normalized
level of RORgt transcripts from cells transduced with E47-ER but treated with ethanol only was set as 1. Similar results were obtained in three
experiments. The bar graph shows the means of quadruplicates 6 SEM.
(F) Reduced RORgt expression in E47-deficient thymocytes. RORgt expression in DP thymocytes from E47+/+ and E472/2mice were analyzed by
QR-PCR. The amounts of RORgt transcripts were normalized to those of the ARP control transcripts. The normalized level of RORgt transcripts
in E47+/+ thymocytes was set as 100. The bar graph shows the means of quadruplicates6 SEM. Representative data are shown from one of two
experiments.
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ER) that contained human E47 fused to the binding do-
main of the murine estrogen receptor (ER), as described
previously (Sayegh et al., 2003). As a control, we overex-
pressed an inducible truncated E47 (bHLH-ER) that
comprised only the DNA binding domains of E47 and
lacked the transactivation domains. RORgt expression
in transduced cells was analyzed by QR-PCR. Enforced
expression of E47-ER followed by 4-hydroxytamoxifen
(4-OHT) treatment to induce dimerization resulted in
a 2-fold (p < 0.01) increase of RORgt expression when
compared to untreated cells transduced with E47-ER
(Figure 4E). Transduction of 1.F9 cells with bHLH-ER
had little effect on RORgt expression (Figure 4E). Treat-
ing the transduced cells with cycloheximide that pre-
vented de novo protein synthesis did not abolish the ac-
tivation of RORgt expression by E47 (data not shown),
suggesting that E47 can directly activate RORgt expres-
sion. This is consistent with the ability of E47 to bind the
E boxes of the RORgt promoter, as described above. To
determine whether E proteins regulate RORgt expres-
sion in vivo, we analyzed RORgt expression in DP thy-
mocytes from E47-deficient mice by QR-PCR. Com-
pared to wild-type thymocytes, RORgt expression in
E47-deficient DP thymocytes was reduced by about
50% (p < 0.01) (Figure 4F). Thus, E proteins positively
regulate RORgt expression.
Role of Id3 in RORgt Promoter Inhibition
The E proteins bind DNA as homo- or heterodimers. The
Id proteins are a family of HLH-containing regulators
that form dimers with E proteins but lack a DNA binding
domain, and as a result prevent the E proteins from bind-
ing DNA (Loveys et al., 1996). It has been proposed that
Egr1 inhibits E protein activity by induction of Id expres-
sion (Bain et al., 2001). We found that coexpression of
a plasmid encoding Id3 along with the 2242 to +109 lu-
ciferase reporter resulted in strong inhibition of RORgt
promoter activity (Figure 5A). A mutant form of Id3
(Loveys et al., 1996) that is unable to bind to E proteins
had no effect in this assay, and Id3 was ineffective at in-
hibition of a reporter construct that had mutant E3 and
E4 boxes. As with Egr3 inhibition, cotransfection of plas-
mids encoding E12 and E47 could overcome the inhibi-
tion mediated by Id3 (Figure 5B). Induction of Id3 by
Egr3 could explain the ability of Egr3 to inhibit RORgt
promoter activity. We found that in thymocytes isolated
from Egr3TG mice, there was a distinct elevation in
amounts of Id3 mRNA as well as Id3 protein (Figures
5C and 5D). Id2 mRNA amounts were only slightly in-
creased. In addition, transduction of D9 cells with Egr3
resulted in a nearly 8-fold increase in Id3 RNA as mea-
sured by QR-PCR (Figure 5E).
To determine whether the inhibition of RORgt expres-
sion by Egr3 in D9 cells required induction of Id3, we ex-
amined RORgt promoter activity after Egr3 transfection
while blocking Id3 induction by means RNA interference
(RNAi). Transfection of D9 cells with an Egr3 expression
vector led to induction of Id3 protein expression, which
was abrogated in the presence of siRNA targeting Id3
(Figure 5F, top). Although the RORgt promoter activity
was decreased by about 50% when cotransfected with
Egr3, the inhibition was abrogated when Id3 induction
was diminished in the presence of Id3 siRNA (Figure 5F,bottom). The data suggest that Egr3 inhibits the RORgt
promoter by inducing Id3, which blocks E protein bind-
ing to the promoter. This model may be slightly more
simplistic than the reality in vivo, because Id3-deficient
mice do not have any apparent defects in the DN to
DP transition (Rivera et al., 2000). This suggests that in
vivo, loss of Id3 may be compensated by other Id family
members or that inhibition of RORgt function by an
Egr3-RORgt interaction (see below) may be sufficient
to delay cell-cycle exit after pre-TCR signaling.
If the model that Egr3 inhibits RORgt expression by
blocking E protein activity is true, then there should be
very little E protein DNA binding activity in the Egr3TG
thymocytes. We tested this by EMSA with nuclear ex-
tracts from Egr3TG thymocytes and littermate controls.
We found that nuclear extracts from Egr3TG thymocytes
contained very little E proteins that could bind to the E
box as compared to littermates (Figure 5G). ChIP assays
also revealed that Egr3TG thymocytes had reduced E
protein DNA binding activities in vivo (Figure S4). Immu-
noblots showed that this was not due to decreased ex-
pression of E12, E47, or HEB (Figure 5H). These data
support a model where Egr3 delays RORgt expression
by induction of Id3, which prevents E protein binding
to the RORgt promoter without changing E protein
expression.
An Interaction between Egr3 and RORgt Regulates
Their Activities
Egr3 expression as a transgene in the thymus results in
a phenotype much like RORgt-deficient mice (Guo et al.,
2002; Kurebayashi et al., 2000; Sun et al., 2000; Xi and
Kersh, 2004b). This could be entirely due to inhibition
of RORgt expression by Egr3, but Egr3TG mice still ex-
press RORgt at 40% of wild-type levels (Xi and Kersh,
2004b). To evaluate the possibility that Egr3 employs
additional mechanisms to regulate RORgt, EGFP along
with FLAG-tagged Egr3, myc-tagged RORgt, or tagged
versions of both Egr3 and RORgt were retrovirally ex-
pressed in D9 cells. We found that expression of either
RORgt or Egr3 resulted in a decline in the percentage
of EGFP+ cells after 3–5 days of culture (Figure 6A). Ex-
amination of cell proliferation by 7-AAD staining and cell
survival by Annexin-V staining revealed that the low per-
centage of RORgt-expressing cells was due to inhibition
of cell division, whereas low numbers of Egr3-express-
ing cells were primarily due to induction of apoptosis
(Figure S5). When both Egr3 and RORgt were expressed
by a tricistronic retroviral vector, the cells grew and sur-
vived nearly as well as when an empty vector was used
(Figure 6A), with no induction of apoptosis or inhibition
of cycling (Figure S5). Immunoblot confirmed that the
transduced proteins were all expressed (Figure 6B).
Thus, even with ectopic expression of RORgt, Egr3 was
able to abrogate the effect of RORgt on the cell cycle.
To determine whether Egr3 was able to prevent
RORgt from inducing target genes, we evaluated ex-
pression of the RORgt targetmCpeb4 after transduction
with RORgt, Egr3, or both. As shown in Figure 6C, ex-
pression of Egr3 alone slightly inhibited mCpeb4 ex-
pression, whereas RORgt induced expression. When
both Egr3 and RORgt were expressed, mCpeb4 expres-
sion was similar to that obtained after transduction with
a retroviral vector encoding only EGFP. ChIP analysis
Immunity
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(A) Repression of the RORgt promoter by Id3 requires intact E boxes. The RORgt promoter containing the wild-type or mutated E3 and E4 E
boxes (10 mg) was cotransfected into D9 cells with increasing amounts (5, 10, 20 mg) of a vector expressing FLAG-Id3 or a FLAG-tagged mutant
Id3 (Id3R72P) that does not bind E proteins. Luciferase activity was analyzed as in Figure 3C. The data show the means 6 SD of a triplicate ex-
periment and represent four similar experiments. The expression of FLAG-Id3 and FLAG-Id3R72P was analyzed by immunoblotting with an anti-
FLAG antibody.
(B) Cotransfection was performed as in Figure 4D, except that an Id3 expression vector (5, 10, 20, 30 mg) replaced the Egr3 expression vector. The
data show the means 6 SD of a triplicate experiment. Similar results were obtained in three separate experiments.
(C) Elevated Id3 expression in Egr3TG thymocytes. Id3 and Id2 expression in thymocytes from four different Egr3TG mice was compared to ex-
pression in thymocytes from four normal littermates by Northern blot. GAPDH expression served as loading control.
(D) Id3 protein expression in Egr3TG thymocytes was assessed by immunoblotting. One representative experiment is shown.
(E) Egr3 induces Id3 expression in DP cells. D9 cells were transduced with the retrovirus expressing GFP only (mock) or Egr3. Id3 expression was
assessed 2 days posttransduction by QR-PCR. The data represent means 6 SD of three experiments.
(F) Inhibition of RORgt promoter by Egr3 is abrogated in the absence of Id3. D9 cells were transfected with siRNAs targeting Id3 or nontargeting
negative control (NC) siRNA. Cells were then cotransfected with pRORgt/2242 and Egr3 expression vector or empty vector (mock). Id3 expres-
sion was analyzed by immunoblotting (top). Luciferase activities (bottom) were measured as described above. The data shown are means6 SD
of three transfection experiments.
(G) Reduced E protein activity in Egr3TG thymocytes. E protein DNA binding activities in Egr3TG thymocytes were analyzed by EMSA with nu-
clear extracts and E3 probes as described in Figure 4B. NS, nonspecific complex. EMSA with an Oct-1 probe was performed to ensure the quan-
tities and qualities of the nuclear extracts.
(H) Normal expression of E12, E47, and HEB in Egr3TG thymocytes. The expression of E12, E47, and HEB was assessed by immunoblotting.
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(A) Egr3 blocks the inhibitory effect of RORgt on DP cell proliferation. D9 cells were transduced with retroviruses expressing either EGFP only
(mock), FLAG-tagged Egr3 plus EGFP, myc-tagged RORgt plus EGFP, or RORgt, Egr3, and EGFP. EGFP expression was analyzed 2 days after
transduction (day 0) by flow cytometry and monitored for the next 8 days. The percentage of remaining GFP+ cells was determined by dividing the
percentage of GFP+ cells at each time point by the percentage of GFP+ cells at day 0. The data represent means 6 SD of three experiments.
(B) Immunoblotting analysis of Egr3 and RORgt expression in transduced D9 cells.
(C) Egr3 abrogates the upregulation of mCPEB4 expression by RORgt. D9 cells were transduced as in (A) and mCPEB4 expression was assessed
by QR-PCR. The data represent means 6 SD of three experiments.
(D) Egr3 blocks the binding of RORgt to the mCpeb4 RORE. Chromatin of D9 cells transduced as above was immunoprecipitated with RORgt
antibody. Precipitated and input DNA was serially diluted (1:1, 1:5, 1:10) and PCR amplified with primers spanning the mCpeb4 RORE as in
Figure 2A.
(E and F) D9 cells were transduced with retroviruses expressing (E) RORgt or RORgt and Egr3 (F) Egr3 or RORgt and Egr3 as in (A). Whole-cell
lysates were immunoprecipitated with antibodies as indicated. The immunoprecipitates were analyzed by immunoblotting with antibodies as
indicated. Immunoblot of the whole-cell lysate served as input control.
(G) Whole-cell lysates from Egr3TG and NLC thymocytes were immunoprecipitated with anti-FLAG antibody and the immunoprecipitates were
analyzed by immunoblotting with anti-RORgt antibody or anti-Egr3 antibody.
(H) Two-hybrid analysis of RORgt and Egr3 interaction. D9 cells were cotransfected with expression vectors expressing pBIND-RORgt and
pACT-Egr3 fusion proteins together with pG5luc luciferase reporter vector. Dual luciferase assays were performed 24 hr after transfection. Co-
transfection with the empty vectors (pBIND and pACT) served as negative control. The data represent the mean 6 SD of four experiments.revealed that expression of Egr3 prevented the endoge-
nously expressed RORgt from binding to the RORE sites
in the third intron of the mCpeb4 gene, whereas overex-
pression of RORgt resulted in enhanced binding to the
mCpeb4 gene (Figure 6D). Expression of both Egr3
and RORgt resulted in reduced binding.
The simplest explanation for the ability of Egr3 to pre-
vent RORgt from inducing a target in D9 cells is that Egr3
is able to interact with RORgt. To test for an interaction
between Egr3 and RORgt, we used a myc antibody toimmunoprecipitate myc-tagged RORgt from D9 cells
transduced with the retrovirus encoding both myc-
tagged RORgt and FLAG-tagged Egr3. Blotting of the
immunoprecipitate with an antibody against FLAG
showed that both RORgt and Egr3 were present (Fig-
ure 6E). Conversely, we were also able to detect RORgt
when we immunoprecipitated Egr3 with a FLAG anti-
body (Figure 6F). To test for this interaction in vivo, we
used the FLAG antibody to immunoprecipitate FLAG-
tagged Egr3 from Egr3TG thymocytes or normal
Immunity
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Black rectangles represent genes and gray rectangles represent proteins. Large boxes indicate high expression and small boxes indicate low
expression. Solid line arrows represent interactions or transitions that have been demonstrated; dashed line arrows represent interactions or
transitions that are likely but have not been shown definitively. The model was depicted by CellDesigner 2.2 (http://celldesigner.org/). When
Egr3 expression is high, Id3 is induced and blocks E protein function by forming heterodimers with E proteins and preventing them from binding
DNA. This leads to low RORgt expression because optimal RORgt expression requires binding of E proteins to the RORgt promoter. Any RORgt
that is produced may be prevented from activating target genes due to binding to Egr3. After Egr3 subsides, RORgt expression and function
increase, leading to quiescence, survival, and TCR a gene rearrangement through RORgt-dependent induction of Cpeb4, Bcl-XL, and Rag2.littermates. We found that the FLAG antibody was able
to precipitate both Egr3 and endogenous RORgt from
Egr3TG thymocyte lysates, indicating that this interac-
tion is maintained in primary thymocytes (Figure 6G).
To verify the interaction of Egr3 and RORgt, we em-
ployed a mammalian two-hybrid system where RORgt
and Egr3 were fused with the GAL4 DNA binding domain
(pBIND-RORgt) and the VP16 activation domain (pAC-
T-Egr3), respectively. The vectors expressing the fusion
proteins were cotransfected with a luciferase reporter
driven by a promoter containing five GAL4 binding sites.
As shown in Figure 6H, the promoter activities were dra-
matically increased only when both RORgt and Egr3 fu-
sion proteins were cotransfected into D9 cells. These
data demonstrate that a specific interaction between
Egr3 and RORgt can take place. This could enable
Egr3 to prevent induction of RORgt target genes, delay-
ing exit from the cell cycle during the DN to DP transition.Whether this interaction occurs in the small number of
normal thymocytes that coexpress Egr3 and RORgt
remains to be determined.
Discussion
Our data support a model where pre-TCR signals are
able to induce a brief period of proliferation because
they not only signal for cell division, but also induce
the molecule that brings an end to cell division (RORgt).
Proliferation is enabled because pre-TCR signals also
induce Egr3, an inhibitor of both RORgt expression
and function. This network is diagrammed in Figure 7,
where the proliferative phase is marked by high Egr3
and Id3, low E protein activity, low RORgt activity, and
low expression of mCPEB4. When Egr3 declines, RORgt
function is enhanced. Id3 also declines, resulting in the
ability of E proteins to form homo- and heterodimers
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RORgt expression. High amounts of active RORgt are
able to induce mCPEB4, and mCPEB4 is then able to re-
move the proliferating cells from the cell cycle. RORgt
also enhances survival by inducing expression of Bcl-
XL, and TCR a gene rearrangement is also promoted
by RORgt-mediated enhancement of Rag2 gene expres-
sion. Because RORgt promotes gene rearrangement
and inhibits cell division, this regulatory network en-
sures that proliferation and gene rearrangement will
not overlap in DP thymocytes.
These findings indicate that transient Egr3 expression
is critical for a normal proliferative phase after pre-TCR
signaling. Indeed, we have found that Egr3-deficient
mice have poor proliferation in response to pre-TCR sig-
naling (Xi and Kersh, 2004a) and that Egr3TG mice
(which have artificially sustained Egr3 expression) have
evidence of enhanced proliferation after pre-TCR signal-
ing but poor survival of the resulting DP cells (Xi and
Kersh, 2004a, 2004b). The implication is that Egr3 must
be induced by pre-TCR signals and only be expressed
transiently so that proliferation will subside and Bcl-XL
will be induced to promote survival. Apparently, the
DP cells become dependent on Bcl-XL for survival at
the end of the proliferative phase, but during prolifera-
tion apoptosis appears to be prevented by another
Bcl-XL family member, Bcl-2A1 (Mandal et al., 2005).
Thus, tightly regulated expression of Egr3 is important
for both limited proliferation and the survival of DP
thymocytes.
Although the mechanism of Egr3 gene regulation in re-
sponse to pre-TCR signals has not been described in
detail, several principles for the regulation of Egr3 have
been established in other cell types. Induction of Egr3
in DP thymocytes in response to TCR signals is depen-
dent on ERK activation and a cyclosporine A (CsA)-sen-
sitive pathway (Shao et al., 1997). Inhibition by CsA im-
plicates NFAT molecules in the regulation of Egr3, and
it has been shown that Egr3 is poorly expressed in T
cells from mice that lack expression of NFATp and
NFAT4 (Rengarajan et al., 2000). The ability of pre-TCR
signals to induce both NFAT translocation to the nucleus
and activation of ERK suggests that these pathways
may be responsible for the induction of Egr3 in response
to pre-TCR signals. The decline in Egr3 expression in
proliferating thymocytes is critical for induction of
RORgt expression and function. Egr3 induction has
been observed in a variety of cell types, and its induction
is always transient. This could be because active ERK is
required for expression to be maintained, and ERK acti-
vation is typically transient. The active, phosphorylated
form of ERK has been shown to be shut off by the action
of MAP kinase phosphatases (Neel and Tonks, 1997;
Tonks and Neel, 2001). Less is known about the half-
life of Egr3 protein, but it seems to be fairly short. In
the case of proliferating thymocytes, even if the protein
had a fairly long half-life, Egr3 protein would decline in
individual cells due to dilution with each successive
cell division. New protein synthesis would be required
in order to maintain the amount of protein in each cell,
and it is clear that Egr3 mRNA has a short half-life.
Once the amount of free RORgt is elevated in thymo-
cytes, one of its effects is to inhibit cell division in DP
thymocytes. RORgt expression in the thymus is con-fined primarily to nondividing DP cells (He, 2002; He
et al., 2000). Transduction of D9 cells with RORgt results
in a reduction of cells in S phase, and RORgt-deficient
mice have a high percentage of thymocytes that are ac-
tively cycling (Sun et al., 2000). We have identified a di-
rect target gene of RORgt, mCpeb4, whose expression
is also able to remove DP thymocytes from the cell cy-
cle. mCPEB4 is part of a family of molecules originally
described in Xenopus extracts (Hake and Richter,
1994). The original CPEB (mCPEB1 in the mouse) has
been shown to bind to the cytoplasmic polyadenylation
element in the 30 untranslated region of specific mRNAs,
and this binding is required for polyadenylation and effi-
cient translation (Mendez and Richter, 2001). InXenopus
embryos, it was demonstrated that translation of cyclin
B1 is dependent on binding of CPEB to its RNA and that
CPEB promoted mitosis by increasing expression of
cyclin B1 protein (Sasayama et al., 2005; Stebbins-
Boaz et al., 1996; Tay et al., 2000). Much less is known
about mCPEB4, but it is possible that mCPEB4 could
target other components of the cell cycle.
In addition to inhibition of RORgt promoter activity, we
have also shown that Egr3 can block RORgt function.
Even when RORgt was ectopically expressed, coex-
pression of Egr3 prevented RORgt from inducing the tar-
get gene mCpeb4. The ability of Egr3 and RORgt to iso-
late together in immunoprecipitates demonstrates that
these two proteins interact in some way. It is not clear
if this interaction is direct or is part of a larger protein
complex. In vivo, RORgt expression is limited immedi-
ately after pre-TCR signaling by high amounts of Egr3.
However, there may still be low expression of RORgt
in thymocytes that have recently experienced a pre-
TCR signal, as shown by the fact that Egr3 is only able
to partially suppress RORgt expression. It remains to
be determined whether the delay in RORgt expression
after pre-TCR signaling is only because of Egr3, or if
time is needed for increases in other factors. The addi-
tional mechanism of Egr3-RORgt interaction may be
necessary to prevent any small amount of RORgt that
is produced in the first few hours after pre-TCR signaling
from inhibiting cell division. This ensures a period of
rapid proliferation that will continue until Egr3 protein
declines.
Experimental Procedures
Mice, Cell Lines, and Plasmids
Egr3TG mice that constitutively express a FLAG-tagged rat Egr3
driven by the CD2 promoter and enhancer in the T cell lineage
were previously described (Xi and Kersh, 2004a). The Emory Univer-
sity Institutional Animal Care and Use Committee approved all pro-
cedures involving animals. 16610D9, a DP thymocyte cell line, was
provided by S. Hedrick (University of California, San Diego, La Jolla,
CA). The 1.F9 cell line was derived from a thymoma developed in an
E2A-deficient mouse (Engel and Murre, 1999). The Phoenix (FNX)
ecotropic packaging cell line was purchased from American Type
Culture Collection (ATCC) with the permission of G. Nolan (Stanford
University, Stanford, CA). The retroviral vector used in these studies,
LZRSpBMN-linker-IRES-EGFP (S-003), was constructed by H. Spits
(The Netherlands Cancer Institute, Amsterdam, Holland) (Hooijberg
et al., 2000). The RORgt expression vector was provided by Y. He
(Duke University, Durham, NC) (He et al., 1998). The FLAG-Egr3 ex-
pression vector was described previously (Xi and Kersh, 2004a). The
tricistronic retroviral vector encoding both RORgt and Egr3 was
constructed by inserting a myc-RORgt-IRES cassette upstream of
FLAG-Egr3 in the S-003 vector that already contained FLAG-Egr3.
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(Columbia University, New York, NY) (Theis et al., 2003), were used
to make S-003 retroviral vector expressing HA-tagged mCPEB4 iso-
forms by PCR. The FLAG-Id3 expression vector was described pre-
viously (Bain et al., 1999). The FLAG-tagged mutant Id3 expression
vector, Id3R72P, was constructed by the QuickChange site-directed
mutagenesis kit (Stratagene). The Id2 expression vector was con-
structed by cloning murine full-length Id2 (obtained by PCR) into
pcDNA3.1 vector (Invitrogen). The E12 and E47 expression vectors
were described previously (Engel and Murre, 1999). The HEB ex-
pression vector, pCDM8-HEB, was obtained from R. Kingston (Har-
vard Medical School, Boston, MA) (Hu et al., 1992). The E12, E47,
and HEB cDNA derived from above plasmids were subcloned into
pcDNA3.1. The bicistronic retroviral constructs expressing E47-ER
or bHLH-ER with hCD25 were described previously (Sayegh et al.,
2003). The full-length mouse RORgt promoter luciferase reporter
construct was described previously (Xi and Kersh, 2004b). Deletion
constructs of the promoter were generated by either restriction en-
zyme digestion or PCR subcloning. E box mutations were generated
by site-directed mutagenesis as follows: E1-TACGTA, E2-CCCTAG,
E3-CCCCAG, E4-CCGCAG.
Retroviral Transduction
The FNX-eco packaging line was transfected with S-003 retroviral
vectors via the SuperFect transfection reagent (QIAGEN). The trans-
fected cells were selected by 2 mg/ml puromycin for about 2 weeks.
Viral supernatants were harvested from stable cell cultures every
24 hr for 3 days and stored at 280ºC. For transduction of D9 cells,
thawed supernatants were incubated with 8 mg/ml polybrene
(Sigma) for at least 10 min on ice. D9 cells in 100 ml of growth media
were added to the supernatants at a ratio of 0.5–13 106 cells per ml
of supernatant in 24-well tissue culture plates. The plates were then
centrifuged at 2800 rpm for 90 min at 32ºC. The cells were incubated
at 37ºC overnight and the dead cells were removed by centrifugation
on Ficoll-Paque Plus gradient (Amersham Biosciences) according to
manufacturer’s instructions. The cells were then cultured in growth
media. Due to low viral titers of viruses encoding mCPEB4 isoforms,
the supernatants were concentrated by 30- to 40-fold prior to trans-
duction. To concentrate the viruses, the viral supernatants were in-
cubated with 80 mg/ml polybrene and 80 mg/ml chondroitin sulfate C
(Sigma) for 20 min at 37ºC, followed by centrifugation at 90003 g for
5 min. The precipitates containing the viruses were resuspended in
desired amount of growth media and used to transduce cells. Typi-
cally 70%–90% transduction efficiency was obtained. Retroviral
transduction of 1.F9 cells with E47-ER or bHLH-ER was performed
as described previously (Engel and Murre, 1999). Transduced cells
were treated with 4-hydroxytamoxifen (4-OHT) as previously de-
scribed (Sayegh et al., 2003).
Chromatin Immunoprecipitation Cloning
ChIP cloning was performed with freshly prepared thymocytes via
a modified version of a published protocol (Weinmann and Farnham,
2002). Nuclear lysates were sonicated to shear DNA to lengths be-
tween 600 and 2000 bps. The lysates were then immunoprecipitated
with RORgt antibody (a gift from Dan Littman, New York University,
New York, NY) or purified hamster IgG. After extensive washing, the
precipitated DNA fragments were purified, blunt-ended by T4 DNA
polymerase, and cloned into the EcoRV site of pBluescript II SK vec-
tor (Stratagene). Standard ChIP assays were performed by a modi-
fied protocol outlined in the ChIP assay kit (Upstate). Cells (20 3
106) were fixed and chromatin sheared by sonication to lengths be-
tween 200 and 1000 bp. Immunprecipitated DNA as well as input
DNA (1%) was analyzed by PCR. The PCR primers are as follows:
E boxes in RORgt promoter, p1, 50-TCATACCCAATGCACCTCTG-
30 (forward), p2, 50-CAGTGGAGGTGGGGTGAA-30 (reverse), p3, 50-
ACCTGTGTGGAGCAGAGCTT-30 (forward), p4, 50-TGCCCCCATTC
ACTTACTTC-30 (reverse); RORE in intron 3 of mCpeb4 gene, 50-
TAAACATCGGCATCCTGCTT-30 (forward), 50-TTTCCCACACCCAC
ATTTCT-30 (reverse).
Northern Blotting and QR-PCR
Total RNA (10 mg) from freshly prepared thymocytes was analyzed
by Northern blotting as described (Bettini et al., 2003). For RNA pu-
rification from DN3 and DN4 thymocytes, thymocytes from threeEgr3+/+ or Egr32/2 mice were pooled. DN cells were enriched by de-
pleting CD4+ cells with magnetic beads (Dynal) according to manu-
facturer’s instructions, followed by staining with cocktail of anti-
bodies against lineage markers (CD4, CD8, CD33, Ter119, Gr-1,
CD11b, CD45R) as well as CD25 and CD44. DN3 and DN4 subsets
were isolated by FACS, and DP cells were purified from the CD4+
cells by means of magnetic beads. For QR-PCR, total RNA was re-
verse transcribed by random hexamers and Superscript II reverse
transcriptase (Invitrogen). The cDNA was analyzed by quantitative
real-time PCR with the Platinum SYBR Green qPCR SuperMix-
UDG system (Invitrogen) on an ABI 5700 (Applied Biosystems). Sam-
ples were amplified in triplicate for 40 cycles with cycle parameters
as follows: 30 s at 95ºC; 1 min at 60ºC. The PCR primers are as fol-
lows: Bcl-XL forward, 5
0-TTCGGGATGGAGTAAACTGG-30, and re-
verse, 50-TGCAATCCGACTCACCAATA-30; Rag1 forward, 50-CCAA
GCTGCAGACATTCTAGCACTC-30, and reverse, 50-CTGGATCCGG
AAAATCCTGGCAATG-30; Rag2 forward, 50-CACATCCACAAGCAG
GAAGTACAC-30, and reverse, 50-GGTTCAGGGACATCTCCTACTA
AG-30; mCpeb4 forward, 50-GAGTCCAGGTCAGGAAGCTG-30, and
reverse, 50-ACCAGTAAGGGACGATGCAC-30; RORgt forward, 50-
TGTCCTGGGCTACCCTACTG-30, and reverse, 50-GTGCAGGAGTA
GGCCACATT-30; Id3 forward, 50-ACTCAGCTTAGCCAGGTGGA-30,
and reverse, 50-GTCAGTGGCAAAAGCTCCTC-30; egr1 forward, 50-
CCACAACAACAGGGAGACCT-30, and reverse, 50-ACTGAGTGGCG
AAGGCTTTA-30; egr3 forward, 50-TGCCCCAACCGCCGCTTACTC
TCA-30, and reverse, 50-GGCGCACCCCCTTTCTCCGACTTC-30; b-
actin forward, 50-AAGTGTGACGTTGACATCCGTAA-30, and reverse,
50-TGCCTGGGTACATGGTGGTA-30. For semiquantitative RT-PCR
of mCPEB4 isoforms, serially diluted (1:1, 1:5, 1:10) cDNA was ampli-
fied by PCR with the primers as follows: forward, 50-CAGGACGTTT
GACATGCACT-30, and reverse, 50-CCATCATCCAGGAATCCATC-30.
For QR-PCR analysis of RORgt expression in transduced 1.F9 cells,
hCD25+ cells were purified by means of MACS beads (Miltenyi Bio-
tech) as previously described (Sayegh et al., 2003). The amounts of
RORgt transcripts were normalized to those of the ARP transcripts
(PRLPO, NM_001002). The PCR primers are as follows: RORgt for-
ward, 50-GCTGTCAAAGTGATCTGGAG-30, and reverse, 50-GGTGGA
ACTTATGGGAAATC-30; ARP forward, 50-CGACCTGGAAGTCCAAC
TAC-30, and reverse, 50-ATCTGCTGCATCTGCTTG-30.
50-RACE
50-RACE was performed with a RNA ligase-mediated rapid amplifi-
cation of cDNA ends (RLM-RACE) kit (Ambion, Austin, TX). PCR
products of 50-end of RORgt mRNA from murine thymocytes were
purified by agarose gel electrophoresis and cloned for sequencing.
Transient Transfection and Reporter Assay
Transfection and luciferase activity analysis was conducted as pre-
viously described (Xi and Kersh, 2003). D9 cells (10 3 106) were
transfected by electroporation with 10 mg of the RORgt promoter lu-
ciferase vector and 0.5 mg Renilla luciferase control vector (pRL-TK)
(Promega). In cotransfection experiments, the total amount of trans-
fected DNA was kept constant by adding the appropriate amount of
empty vector. Dual luciferase assays were performed with the Dual-
Luciferase Reporter Assay System (Promega).
RNA Interference
A mixture of four siRNAs (SMARTPool siRNA) specific for Id3 and
nontargeting negative control siRNA were purchased from Dharma-
con. D9 cells were seeded at a density of 5–8 3 105 cells per well of
a 24-well plate in growth medium without antibiotics. Cells were
transfected with 100 nM siRNA via Lipofectamine 2000 (Invitrogen)
according to manufacturer’s instructions. The cells were harvested
40–48 hr posttransfection. The cells were then cotransfected with
the RORgt promoter and Egr3 expression vector by means of Lipo-
fectamine 2000. Luciferase activities were measured 24 hr later. Id3
expression was analyzed by immunoblotting.
Electrophoretic Mobility Shift Assay
Nuclear extracts were prepared as described previously (Xi and
Kersh, 2003). Binding reactions were performed with 5 mg of extract
and the indicated oligonucleotide probes. For binding competition
experiments, extracts were preincubated with 100-fold molar ex-
cess of unlabeled oligonucleotide containing the wild-type or
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added. The sequences of the oligonucleotides are available upon re-
quest. For antibody supershifting analysis, extracts were preincu-
bated with 1 mg of E12 (H-208), E47 (N-649), HEB (A-20), or rabbit
control antibody (all from Santa Cruz Biotechnology). The binding
reactions were electrophoresed as described previously (Xi and
Kersh, 2003).
Coimmunoprecipitation and Immunoblotting Assay
Whole-cell lysates were prepared as described (Xi and Kersh, 2003).
For the immunoprecipitation, 500 mg to 1 mg of whole cell lysates
were precleared with isotype control antibody, and the precleared
lysates were incubated with washed anti-c-myc agarose conjugate
(Sigma) or anti-FLAG M2 affinity gel (Sigma) overnight on a shaker
at 4ºC. After extensive washing, the immunocomplexes were resus-
pended in SDS sample buffer and incubated 5 min at 95ºC. The sam-
ples are centrifuged and the supernatants were analyzed by SDS-
PAGE and immunoblotting as described previously (Xi and Kersh,
2003). The antibodies used are as follows: anti-FLAG M2, anti-b-
actin (AC-15) (Sigma), anti-myc-tag (9B11), anti-HA-tag (262K) (Cell
Signaling Technology), anti-Id3 (H-70), anti-Egr3 (C-24) (Santa Cruz
Biotechnology), anti-Bcl-X (BD Biosciences), and anti-RORgt
(D. Littman).
Mammalian Two-Hybrid Assay
Two-hybrid assay was performed with the CheckMate mammalian
two-hybrid system (Promega). The coding regions of RORgt and
Egr3 were subcloned in-frame into pBIND (which contains the
Renilla luciferase gene) and pACT vectors, respectively. Equal
amounts (10 mg) of pBIND-RORgt or pACT-Egr3 or both were co-
transfected with the pG5luc luciferase reporter (10 mg) into 10 3
106 D9 cells by electroporation. Cotransfection of pBIND-RORgt
with pACT or pACT-Egr3 with pBIND served as negative control.
Dual luciferase assays were performed 24 hr posttransfection as
described above.
Supplemental Data
Five Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/24/6/813/DC1/.
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